Question 1

What is the catalog number for 5,6,7,8-Tetrahydroquinolin-2-amine?

Accepted Answer

The catalog number for 5,6,7,8-Tetrahydroquinolin-2-amine is FT176602.

Question 2

What sizes are available for 5,6,7,8-Tetrahydroquinolin-2-amine?

Accepted Answer

5,6,7,8-Tetrahydroquinolin-2-amine is available in the following size(s): 5 mg, 10 mg, 25 mg, 50 mg.

Question 3

How many pack sizes does 5,6,7,8-Tetrahydroquinolin-2-amine come in?

Accepted Answer

5,6,7,8-Tetrahydroquinolin-2-amine is available in 4 different pack sizes.

Question 4

Is 5,6,7,8-Tetrahydroquinolin-2-amine in stock?

Accepted Answer

5,6,7,8-Tetrahydroquinolin-2-amine is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Question 6

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

Question 7

Do you offer bulk or custom quantities of this product?

Accepted Answer

Yes. Ordering two or more units, or combining this with other products, usually qualifies for a discount depending on quantity. Contact our sales team with your required volume for a custom quote.

5,6,7,8-Tetrahydroquinolin-2-amine

Product Specifications

CAS Number

MDL Number

Smiles

Molecular Formula

Molecular Weight

Controlled

Available Sizes

Frequently Asked Questions

Explore Other Products

ICOS-L / ICOS Ligand / B7RP-1 (Immuno-Oncology Target) (ICOSL/3260), CF640R conjugate, 0.1mg/mL

IFluor® 680 goat anti-rabbit IgG (H+L)

Human TNF-a ELISA Kit (96-well)

rac Quinacrine-d10 Dihydrochloride

Optional dimpled mat for use with a variety of tubes

ARK5 (NUAK1) Human Gene Knockout Kit (CRISPR)